Russian researchers develop biocompatible magnetic microparticles as safer alternative to brain electrodes

A team of Russian researchers has engineered tiny magnetic particles that can stimulate nerve tissue without the risks of traditional brain electrodes—a development that could reshape how doctors treat severe neurological conditions when medication fails. The work, published in Advanced Functional Materials, emerged from Skoltech and collaborating institutions including the Institute of Cytology and Genetics of SB RAS, and it demonstrates something previously unproven: that nontoxic magnetic microparticles can wirelessly control involuntary functions in a living animal.

The problem the researchers are trying to solve is both practical and visceral. Brain electrodes—five-centimeter pieces of metal surgically implanted into the skull—remain the last resort for patients with treatment-resistant epilepsy, Parkinson's disease, and a growing list of other conditions including dementia, chronic pain, and obsessive-compulsive disorder. They work. But as Gleb Sukhorukov, the study's co-author and head of Skoltech's Center for Bio- and Medical Technologies, notes, holding one of these electrodes in your hand or seeing it on a brain scan raises an obvious question: must we really put metal that large inside someone's head?

The microparticles Sukhorukov's team designed are roughly the size of individual neurons—small enough to be delivered by injection, and potentially by enhanced nasal delivery if the researchers can shrink them further by a factor of ten. Each particle is a hockey puck-shaped composite made of polylactic acid, a degradable polymer that looks like milky-white plastic, embedded with tiny rods of iron oxide. This composition matters enormously. Previous attempts at magnetic neural stimulation used cobalt or nickel, both toxic metals. These particles are free of toxins.

The manufacturing process is elegant. Magnetic nanorods are added to a polylactic acid solution and poured into microwells sized to match the desired particle diameter. The material crystallizes in the presence of a magnetic field, which aligns all the metal rods like compass needles pointing the same direction. This alignment is essential for the particles to work. When a variable magnetic field activates the microparticles later, the metal rods press against the polymer, which is piezoelectric—meaning it generates electricity under mechanical stress. That electrical pulse is what stimulates the nerve.

In the experiment, the team surgically placed these particles in contact with the vagus nerve of a mouse, the nerve that controls heart rate, breathing, digestion, and other involuntary functions. When they activated the magnetic field, the particles generated electrical pulses that altered the mouse's breathing and heart rate. The researchers observed increased respiratory rate and decreased heart rate once the activation threshold was exceeded. It was the first animal model demonstration that nontoxic magnetic microparticles could modulate these involuntary processes.

What makes this work significant is not just the proof of concept but the pathway it opens. The same approach can activate neural pathways anywhere in the nervous system—brain, spinal cord, or peripheral nerves. Sukhorukov and his team plan to begin modeling specific neurological disorders in mice this year, starting with concussion. If those experiments succeed, the next steps would involve testing in larger animals and eventually human trials. The vision is clear: a patient with severe epilepsy or Parkinson's disease could receive an injection of these biocompatible particles rather than undergo brain surgery. The particles would settle into place, and stimulation would come wirelessly from outside the body.

The work is supported by a Russian Science Foundation grant and represents years of research into an approach that, while not entirely new, has never before been executed with nontoxic materials at this scale. It sits at the intersection of materials science, neurology, and engineering—the kind of problem that requires expertise across disciplines. For patients and families facing the choice between living with a severe neurological condition or accepting the risks of electrode implantation, this research offers something that has been missing: a genuinely different option.